BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 12, 2010
View Archived Issues
Common Denominator of Cardiac, Vascular Disease
Read More
Biogen, Gilead, Others Warned About Misleading Promotions
Read More
Other News To Note
Read More
Stock Movers
Read More
Financings Roundup
Read More
Clinic Roundup
Read More
U.S. Patent Disclosures
Read More
Bench Press
Read More
Tengion Prices $30M IPO Despite Early Stage, High-Risk Programs
Tengion Inc., which priced a $30 million initial public offering on Friday, was easily the earliest-stage biotech to try its luck in the current IPO window. (BioWorld Today)
Read More
FDA Rejects CTI Lymphoma Drug; Firm to Seek Compassionate Use
Read More